Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -32.3% | -141.9% | 1 / 3 | +12.4% | -5.99 pp | -3.20 pp | +7.0% | 0.06 | 14.85 | 210 | +12,4% | 20,0 | −15,9% | 14.85 | 15.90 | −6,6% |
| Pts | 0 | 0 | 4 | 4 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 17.100 (close price on 2026-10-19)EPS (TTM): 1.152
Financial charts
1.Revenue & growth
VND bn210Q2/26
1.Revenue & growth
VND bn210Q2/26
2.Profit & growth
VND bn20,7Q2/26
3.Profit mix (Penman)
VND bn68,6Q2/26
4.Margins & cost structure
%30.6%Q2/26
5.Returns & cash cycle
% · days8.4%Q2/26
6.Earnings quality & cash
VND bn168Q2/26
7.Asset structure
VND bn818Q2/26
8.Funding & debt health
VND bn · times818Q2/26
9.Revenue backlog
VND bn3,89Q2/26
10.Valuation
times · %15,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %478Q2/26
Adjusted EPS growth, latest quarter
-32.3%
Average adjusted EPS growth, 3 quarters
-142%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
22.2%
Source: vnstockData through Q2/26